Principal Investigator
Maria Carpintero
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230938
Clinical Trial Summary
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants with Sjgren’s Syndrome with Moderate-to-severe Systemic Disease Activity
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Niurka Colina
Phone Number
+1 (305) 2436405
Email
nxc610@miami.edu